Advertisement

Affymax, Inc. AFFY

Set alert

Price alert · AFFY

All alert types
0.00 USD 0.00 0.00%

At close · Oct 30

0.0009 Day range 0.0009
0.0007 52-week range 0.0416
YTD
0.00%
1 year
0.00%
Open
0.0009
Prev close
0.0008
Mkt cap
29.99K
Vol
6.00K
Avg vol
1.17K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0009
High
0.0009
Forward P/E
0.00
Beta
2.14
Short ratio
2.35
Inst. own
0.00%
Dividend
0.00
Ex-div date
Nov 27, 2014
Earnings
May 6, 2014
50-d avg
0.074286
200-d avg
0.073304
1y target
1.00

3M chart

Chart tools
Interval

Signals (24)
NameDateAgo
MACD: Sell SignalOct 21, 20261 week ago
SMA: BearishOct 20, 20261 week ago
SMA: BearishOct 20, 20261 week ago
SMA: BullishOct 9, 20263 weeks ago
SMA: BullishOct 9, 20263 weeks ago
MACD: Buy SignalOct 9, 20263 weeks ago
RSI: OverboughtOct 9, 20263 weeks ago
MACD: Sell SignalSep 10, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BearishSep 8, 20261 month ago
MACD: Buy SignalSep 3, 20261 month ago
RSI: OverboughtSep 3, 20261 month ago
MACD: Sell SignalSep 1, 20262 months ago
MACD: Buy SignalAug 17, 20262 months ago
SMA: BullishAug 14, 20262 months ago
SMA: BullishAug 14, 20262 months ago
SMA: BearishAug 12, 20262 months ago
SMA: BearishAug 12, 20262 months ago
MACD: Sell SignalAug 12, 20262 months ago
RSI: OversoldAug 12, 20262 months ago
SMA: BullishJul 30, 20263 months ago
SMA: BullishJul 30, 20263 months ago
MACD: Buy SignalJul 30, 20263 months ago
RSI: OverboughtJul 30, 20263 months ago

Key statistics

Market cap
2.55M
Enterprise value
-774.69K
Trailing P/E
0.83
Forward P/E
0.00
PEG ratio
0.00
Price / sales
60.70
Price / book
0.49
EPS (TTM)
0.082
Beta
2.14
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
7300.00%
Revenue (TTM)
42.00K
Revenue growth
-92.00%
Free cash flow
-41.41M
Total cash
3.40M
Total debt
0
Return on equity
111.59%
Shares outstanding
37.49M
Short % of float
49.35%
50-day average
0.074286
200-day average
0.073304

Analyst view

Consensus: hold

Hold
Price target (mean) 1.00

Next earnings

May 6, 2014

Expected May 6, 2014. Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
AFFY Revenue — quarterly 42.00K
2010-Q3 20102010-Q4 20102011-Q1 20112011-Q2 20112011-Q3 20112011-Q4 20112012-Q1 20122012-Q2 20122012-Q3 20122012-Q4 20122013-Q1 20132013-Q2 20132013-Q3 20132013-Q4 20132014-Q1 20142014-Q2 2014
AFFY Net income — quarterly 7.21M
2010-Q3 20102010-Q4 20102011-Q1 20112011-Q2 20112011-Q3 20112011-Q4 20112012-Q1 20122012-Q2 20122012-Q3 20122012-Q4 20122013-Q1 20132013-Q2 20132013-Q3 20132013-Q4 20132014-Q1 20142014-Q2 2014
AFFY EPS — quarterly 0.19
2010-Q3 20102010-Q4 20102011-Q1 20112011-Q2 20112011-Q3 20112011-Q4 20112012-Q1 20122012-Q2 20122012-Q3 20122012-Q4 20122013-Q1 20132013-Q2 20132013-Q3 20132013-Q4 20132014-Q1 20142014-Q2 2014

Earnings

AFFY recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
May 6, 2014Mar 1, 20140.00———
Mar 31, 2014Dec 1, 20130.00———

Upgrades / downgrades

AFFY analyst upgrades and downgrades
DateFirmActionFromTo
Sep 17, 2013WBB SecuritiesdownBuyHold
Mar 18, 2013MLV & CodownHoldSell
Feb 24, 2013Stifel NicolausdownBuyHold
Feb 24, 2013Robert W. BairddownOutperformNeutral
Feb 24, 2013MLV & CodownBuyHold
May 7, 2012WBB SecuritiesdownStrong BuyBuy

About Affymax, Inc.

Affymax, Inc. does not have significant operations. Previously, it was developing drugs to enhance the treatment of serious and often life-threatening conditions in the United States. The company was founded in 2001 and is based in New York, New York.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Website
affymax.com

News

Your note

Sign in to keep a note on AFFY — it syncs with the Stock Master app.

Advertisement